From the Beacon: “the antidepressant paroxetine (marketed as Aropax) reduces the effectiveness of Tamoxifen and should be avoided by women taking Tamoxifen. There is a possibility that some other antidepressants may, to a small degree, affect the metabolism of Tamoxifen… Women taking aromotase inhibitors [e.g. Arimidex or Letrozole] are not affected by this—antidepressants do not reduce the effectiveness of aromotase inhibitors.”
No comments:
Post a Comment